175 related articles for article (PubMed ID: 12490784)
1. Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts.
Shapiro AM; Geng Hao E; Lakey JR; Finegood DT; Rajotte RV; Kneteman NM
Transplantation; 2002 Dec; 74(11):1522-8. PubMed ID: 12490784
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of glucocorticoid-free immunosuppressive regimen in allogenic islet transplantation.
Du CY; Xu EK
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):43-7. PubMed ID: 16481281
[TBL] [Abstract][Full Text] [Related]
3. Intrathymic islet transplantation in the canine: I. Histological and functional evidence of autologous intrathymic islet engraftment and survival in pancreatectomized recipients.
Levy MM; Ketchum RJ; Tomaszewski JE; Naji A; Barker CF; Brayman KL
Transplantation; 2002 Mar; 73(6):842-52. PubMed ID: 11923682
[TBL] [Abstract][Full Text] [Related]
4. The effect of transplantation site and islet mass on long-term survival and metabolic and hormonal function of canine purified islet autografts.
Scharp DW; Marchetti P; Swanson C; Newton M; McCullough CS; Olack B
Cell Transplant; 1992; 1(2-3):245-54. PubMed ID: 1344296
[TBL] [Abstract][Full Text] [Related]
5. Islet transplantation in patients with diabetes mellitus: choice of immunosuppression.
Nanji SA; Shapiro AM
BioDrugs; 2004; 18(5):315-28. PubMed ID: 15377174
[TBL] [Abstract][Full Text] [Related]
6. The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients.
Kneteman NM; Lakey JR; Wagner T; Finegood D
Transplantation; 1996 Apr; 61(8):1206-10. PubMed ID: 8610419
[TBL] [Abstract][Full Text] [Related]
7. Purified canine islet autografts. Functional outcome as influenced by islet number and implantation site.
Kaufman DB; Morel P; Field MJ; Munn SR; Sutherland DE
Transplantation; 1990 Sep; 50(3):385-91. PubMed ID: 2169662
[TBL] [Abstract][Full Text] [Related]
8. Long-term normoglycemia in pancreatectomized dogs following pancreatic islet allotransplantation and cyclosporine immunosuppression.
Kneteman NM; Alderson D; Scharp DW
Transplantation; 1987 Nov; 44(5):595-9. PubMed ID: 3120377
[TBL] [Abstract][Full Text] [Related]
9. Long-term functional islet mass and metabolic function after xenoislet transplantation in primates.
Contreras JL; Eckhoff DE; Cartner S; Bilbao G; Ricordi C; Neville DM; Thomas FT; Thomas JM
Transplantation; 2000 Jan; 69(2):195-201. PubMed ID: 10670626
[TBL] [Abstract][Full Text] [Related]
10. Acceleration of chronic failure of intrahepatic canine islet autografts by a short course of prednisone.
Rilo HL; Carroll PB; Zeng YJ; Fontes P; Demetris J; Ricordi C
Transplantation; 1994 Jan; 57(2):181-7. PubMed ID: 8310505
[TBL] [Abstract][Full Text] [Related]
11. Similar islet function in islet allotransplant and autotransplant recipients, despite lower islet mass in autotransplants.
Bellin MD; Sutherland DE; Beilman GJ; Hong-McAtee I; Balamurugan AN; Hering BJ; Moran A
Transplantation; 2011 Feb; 91(3):367-72. PubMed ID: 21228753
[TBL] [Abstract][Full Text] [Related]
12. Canine islet autografts with and without administration of cyclosporine.
Gores PF; Boudreaux JP; Hesse UJ; Najarian JS; Sutherland DE
Surgery; 1987 May; 101(5):557-61. PubMed ID: 3107155
[TBL] [Abstract][Full Text] [Related]
13. Markedly reduced beta-cell function does not result in insulin resistance in islet autografted dogs.
Tobin BW; Lewis JT; Tobin BL; Rajotte RV; Finegood DT
Diabetes; 1992 Sep; 41(9):1172-81. PubMed ID: 1499868
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression and pancreatic islet transplantation.
Kneteman NM; Cattral MC; Warnock GL; Scharp DW; Jaspan JL; Rajotte RV
Horm Metab Res Suppl; 1990; 25():193-9. PubMed ID: 2088967
[TBL] [Abstract][Full Text] [Related]
15. Assessing the effect of immunosuppression on engraftment of pancreatic islets.
Vallabhajosyula P; Hirakata A; Shimizu A; Okumi M; Tchipashvili V; Hong H; Yamada K; Sachs DH
Transplantation; 2013 Aug; 96(4):372-8. PubMed ID: 23883972
[TBL] [Abstract][Full Text] [Related]
16. Assessment of long-term (1 year) graft survival and metabolic and hormonal changes after intrasplenic canine pancreatic microfragment transplantation.
Marchetti P; Olack B; Swanson C; Newton M; Scharp DW
Diabete Metab; 1993; 19(1):17-24. PubMed ID: 8504880
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of dispersed pancreatic islet tissue in humans: autografts and allografts.
Sutherland DE; Matas AJ; Goetz FC; Najarian JS
Diabetes; 1980; 29 Suppl 1():31-44. PubMed ID: 6766413
[TBL] [Abstract][Full Text] [Related]
18. Beneficial and detrimental effects of RBC-adsorbed antilymphocyte globulin and prednisone on purified canine islet autograft and allograft function.
Kaufman DB; Morel P; Condie R; Field MJ; Rooney M; Tzardis P; Stock P; Sutherland DE
Transplantation; 1991 Jan; 51(1):37-42. PubMed ID: 1987703
[TBL] [Abstract][Full Text] [Related]
19. Failure of canine islet allografts and autografts with cyclosporine.
Merrell RC; Mahoney ME; Basadonna G; Cobb LF; Maeda M
Surgery; 1985 Aug; 98(2):324-9. PubMed ID: 3927498
[TBL] [Abstract][Full Text] [Related]
20. Long-term insulin independence following repeated islet transplantation in totally pancreatectomized diabetic pigs.
Morsiani E; Fogli L; Lanza G; Lebow LT; Demetriou AA; Rozga J
Cell Transplant; 2002; 11(1):55-66. PubMed ID: 12095221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
